Index of artpub/2025/320642/

Cortellini, Alessio
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials : results from the Pembro-real 5Y global registry
2025
https://ddd.uab.cat/record/320642